跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levixam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levixam
Approved
STANDARD
Levixam
Hainan Poly Pharm. Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b19b26cd4aa3a2c4
Company
Hainan Poly Pharm. Co., Ltd
Type
Standard
Approval Details
Approval Id
b19b26cd4aa3a2c4
Drug Approval Philippines Name
Levixam
Product Name
Levixam
Registration Number
DRP-11179-01
Brand Name
Levixam
Generic Name
Levetiracetam
Dosage Form
Solution for Injection (IV)
Dosage Strength
100 mg/mL (500 mg/5 mL)
Manufacturer
Hainan Poly Pharm. Co., Ltd
Importer
Ambica International Corporation
Distributor
Uni-Pharma Phils., Inc
Company Detail Path
/organization/hainan-poly-pharm-co-ltd-haikou-hainan-china
Issuance Date
19 October 2023
Expiry Date
10 February 2027
Pharmacologic Category
Antiepileptic
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b19b26cd4aa3a2c4
Type
Standard
Back to Philippines FDA Approvals